Search

everythinglearnresearchcommunity

for

Search:↓

Good communication helps predict successful aging in older Indonesians.

Oreo the dog got better from skin and worm infections after treatment and cleaner living conditions.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Gender-affirming dermatology treatments generally improve mental well-being for transgender individuals, but more research is needed.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

PRGF treatments increased hair number and thickness in people with hair loss, with more injections leading to better results.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Mindfulness reduces anxiety and depression in skin disease patients; dermatologists and psychiatrists often lack confidence in treating psychodermatological conditions.

Natesto nasal gel improves erectile function and mood in men with low testosterone within 30 days.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Alopecia patients have less GPER-1, which might affect hair loss.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

The document concludes that "Dictamnus" has a rich cultural history and potential as a herbal medicine, warranting more research into its effects and safety.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

The document concludes that validated methods are needed to ensure the quality of fluconazole drugs and that new antifungal medications are necessary due to safety and resistance concerns.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Fluconazole is an effective antifungal medication with potential side effects and lacks official analytical methods for its determination.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

Dogs with dermatitis show significant skin changes and higher white blood cell counts.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

The dog's condition improved after 21 days of treatment.

COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.

Testosterone in older women can increase bone density, muscle mass, fat mass, improve memory, and boost libido, but may cause nipple color changes.